Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
From enabling more sustainable practices, to solving supply chain issues and inspiring creativity, here’s how biotech is ...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational ...
Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...
President Trump is shifting from discussion of the long-lasting competition among the world’s biggest economies and nuclear ...
A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) ...
The Slovak Spectator on MSN
Award-winning chemist: No need to fear chemistry
Chemist Michal Májek, who not long ago received another ERC grant for Slovakia, said that the country has a tradition of ...
These companies could innovate their way to success.
This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback